Abiopharma

News list

Charette Austin 🟢 acquired 22.6K shares (2 derivative) of AGENUS INC (AGEN) at $3.90 Transaction Date: Apr 24, 2026 | Filing ID: 187080

Full text

News bot April 28, 2026, 8:16 p.m.
🔍 Charette Austin (Executive)

Company: AGENUS INC (AGEN)

Report Date: 2026-04-24
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 2
- Holdings reported: 0
- Total shares acquired: 22,619
Detailed Transactions and Holdings:
- Acquired 5,000 shares of Stock Option at $3.9 per share (Derivative)
  Date: 2026-04-24 | Code: A | Expires: 2036-04-24 | equity_swap_involved: false | shares_owned_after: 5,000.00 | transaction_form_type: 4 | Footnotes: F1
- Acquired 17,619 shares of Stock Option at $3.9 per share (Derivative)
  Date: 2026-04-24 | Code: A | Expires: 2036-04-24 | equity_swap_involved: false | shares_owned_after: 17,619.00 | transaction_form_type: 4 | Footnotes: F2
Footnotes:
- F1: Option awarded in accordance with the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan, and vests over three years with one-third of the award vesting on April 24, 2027, and the balance vesting in equal quarterly installments thereafter.
- F2: Option awarded in lieu of the 2025 annual cash bonus and in accordance with the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan. Vests in full on May 24, 2026.